Biotech Investing BriaCell's Bria-OTS+ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal 26 August
Biotech Investing BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+ in Prostate Cancer 25 August
